Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
ICD-10 F13.980 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder.
F13.980 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances that leads to anxiety disorders. Patients may misuse these substances for their calming effects, but prolonged use can result in dependence and withdrawal symptoms. The anxiety disorder induced by these substances can manifest as excessive worry, restlessness, and physical symptoms such as increased heart rate and sweating. This code is used when the specific substance is not identified, but the clinical picture indicates a clear link between substance use and anxiety symptoms. Treatment often involves a combination of psychotherapy and medication management, focusing on both the substance use disorder and the anxiety disorder. Clinicians must carefully assess the patient's history and current symptoms to provide appropriate care and avoid exacerbating the anxiety through withdrawal or misuse of other substances.
Detailed patient history, including substance use patterns and anxiety symptoms.
Patients presenting with anxiety symptoms after recent sedative use.
Consideration of co-occurring mental health disorders and substance use history.
Comprehensive assessment of substance use history and treatment plans.
Patients undergoing detoxification from sedatives with concurrent anxiety symptoms.
Focus on withdrawal management and potential for relapse.
Used for follow-up visits for patients with anxiety and substance use issues.
Document history, examination, and medical decision-making.
Psychiatric evaluations may require additional documentation.
The unspecified nature indicates that the specific sedative, hypnotic, or anxiolytic is not documented, which can complicate treatment and coding. It is crucial for providers to specify the substance when possible to ensure accurate treatment and billing.
